Nuvation Bio (NUVB) Operating Leases (2023 - 2025)
Historic Operating Leases for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $3.0 million.
- Nuvation Bio's Operating Leases rose 20152.28% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 20152.28%. This contributed to the annual value of $969000.0 for FY2024, which is 5238.33% down from last year.
- According to the latest figures from Q3 2025, Nuvation Bio's Operating Leases is $3.0 million, which was up 20152.28% from $3.4 million recorded in Q2 2025.
- In the past 5 years, Nuvation Bio's Operating Leases registered a high of $3.8 million during Q1 2025, and its lowest value of $969000.0 during Q4 2024.
- In the last 3 years, Nuvation Bio's Operating Leases had a median value of $2.4 million in 2023 and averaged $2.2 million.
- Its Operating Leases has fluctuated over the past 5 years, first plummeted by 6135.74% in 2024, then skyrocketed by 24969.14% in 2025.
- Over the past 3 years, Nuvation Bio's Operating Leases (Quarter) stood at $2.0 million in 2023, then crashed by 52.38% to $969000.0 in 2024, then soared by 206.5% to $3.0 million in 2025.
- Its Operating Leases stands at $3.0 million for Q3 2025, versus $3.4 million for Q2 2025 and $3.8 million for Q1 2025.